Home / Recalls / Upsher Smith Laboratories, Inc. / D-1836-2019

D-1836-2019 Class II Terminated

Recalled by Upsher Smith Laboratories, Inc. — Maple Grove, MN

Recall Details

Product Type
Drugs
Report Date
August 28, 2019
Initiation Date
July 29, 2019
Termination Date
August 25, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
166 bottles

Product Description

Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple Grove, MN 55369. NDC: 0832-0285-00

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

KY, OH, NJ, LA

Code Information

Lot: A2610. exp 3/2020

Other recalls by Upsher Smith Laboratories, Inc.

  • D-0280-2019 Class II — Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upse (September 19, 2018)
  • D-0281-2019 Class II — Bumetanide Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured by: Upse (September 19, 2018)
  • D-1255-2014 Class III — Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured f (April 14, 2014)
  • D-127-2013 Class III — Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 1 (December 10, 2012)
  • D-160-2013 Class II — Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, R (November 20, 2012)